Asosiy kontentga oʻtish
Maqola

Diagnostic Markers AND Cytokine Profile in Rheumatoid Arthritis During Basic Therapy

A. S. (Anvarxodjaeva) GTashkent State Medical UniversityE. A. ШакунTashkent State Medical University
2025en
ABI

Annotatsiya

The aim of this study was to evaluate the diagnostic and prognostic significance of anti-mutated citrullinated vimentin (anti-MCV) antibodies, anti-keratin antibodies (AKA), and interleukin-6 (IL-6) in patients with rheumatoid arthritis (RA) undergoing methotrexate-based therapy. A 12-month prospective observational study was conducted involving 76 patients with both early and established RA. A comprehensive assessment was performed, including clinical disease activity evaluation, serum levels of anti-MCV, AKA, rheumatoid factor (RF), and IL-6, as well as dynamic radiographic monitoring. Elevated levels of anti-MCV and IL-6 were found to be associated with high inflammatory activity and rapid progression of joint erosions. Notably, anti-MCV showed particular diagnostic value in patients with seronegative RA. A reduction in anti-MCV and IL-6 levels correlated with the achievement of clinical remission during therapy. The novelty of this study lies in demonstrating the prognostic value of anti-MCV and IL-6 as biomarkers for monitoring the long-term effectiveness of RA treatment.

Hali tarjima qilinmagan

Iqtiboslar va manbalar